David D O'Toole Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for David D O'Toole.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of David D O'Toole. David D O'Toole is Chief Financial Officer in RESPONSE GENETICS INC ($RGDX) and Vice President & CFO in RESPONSE GENETICS INC ($RGDX) and Chief Financial Officer in OPIANT PHARMACEUTICALS, INC. ($OPNT) and Chief Financial Officer in Capnia, Inc. ($CAPN) and See Remarks in Capnia, Inc. ($CAPN) and SVP & Chief Financial Officer in Capnia, Inc. ($CAPN).
Latest Insider Trading Transactions of David D O'Toole
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, OPNT, RGDX, SLNO
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 27 2021 | OPNT | OPIANT PHARMACEUTI ... | O'Toole David D | Chief Financial Off ... | Option Exercise | A | 12.15 | 10,750 | 130,613 | 10,750 | |
| Jan 27 2021 | OPNT | OPIANT PHARMACEUTI ... | O'Toole David D | Chief Financial Off ... | Grant | A | 0.00 | 5,400 | 0 | 23,215 | 17.8 K to 23.2 K (+30.31 %) |
| Jan 27 2021 | OPNT | OPIANT PHARMACEUTI ... | O'Toole David D | Chief Financial Off ... | Grant | A | 0.00 | 2,450 | 0 | 17,815 | 15.4 K to 17.8 K (+15.95 %) |
| Jun 11 2020 | OPNT | OPIANT PHARMACEUTI ... | O'Toole David D | Chief Financial Off ... | Buy | P | 8.74 | 1,000 | 8,740 | 15,365 | 14.4 K to 15.4 K (+6.96 %) |
| May 26 2020 | OPNT | OPIANT PHARMACEUTI ... | O'Toole David D | Chief Financial Off ... | Buy | P | 11.00 | 1,000 | 11,000 | 14,365 | 13.4 K to 14.4 K (+7.48 %) |
| Jan 09 2020 | OPNT | OPIANT PHARMACEUTI ... | O'Toole David D | Chief Financial Off ... | Option Exercise | A | 13.60 | 8,250 | 112,200 | 8,250 | |
| Jan 09 2020 | OPNT | OPIANT PHARMACEUTI ... | O'Toole David D | Chief Financial Off ... | Grant | A | 0.00 | 4,150 | 0 | 13,365 | 9.2 K to 13.4 K (+45.04 %) |
| Nov 26 2019 | OPNT | OPIANT PHARMACEUTI ... | O'Toole David D | Chief Financial Off ... | Buy | P | 13.22 | 100 | 1,322 | 9,215 | 9.1 K to 9.2 K (+1.10 %) |
| Nov 15 2019 | OPNT | OPIANT PHARMACEUTI ... | O'Toole David D | Chief Financial Off ... | Buy | P | 15.00 | 100 | 1,500 | 9,115 | 9 K to 9.1 K (+1.11 %) |
| Nov 15 2019 | OPNT | OPIANT PHARMACEUTI ... | O'Toole David D | Chief Financial Off ... | Buy | P | 14.91 | 1,000 | 14,910 | 9,015 | 8 K to 9 K (+12.48 %) |
| Aug 15 2019 | OPNT | OPIANT PHARMACEUTI ... | O'Toole David D | Chief Financial Off ... | Buy | P | 15.20 | 1,000 | 15,200 | 8,015 | 7 K to 8 K (+14.26 %) |
| Aug 15 2019 | OPNT | OPIANT PHARMACEUTI ... | O'Toole David D | Chief Financial Off ... | Buy | P | 15.20 | 1,000 | 15,200 | 8,015 | 7 K to 8 K (+14.26 %) |
| Aug 13 2019 | OPNT | OPIANT PHARMACEUTI ... | O'Toole David D | Chief Financial Off ... | Buy | P | 15.46 | 1,000 | 15,460 | 7,015 | 6 K to 7 K (+16.63 %) |
| Jan 04 2019 | OPNT | OPIANT PHARMACEUTI ... | O'Toole David D | Chief Financial Off ... | Option Exercise | A | 13.61 | 33,000 | 449,130 | 33,000 | |
| May 16 2018 | OPNT | OPIANT PHARMACEUTI ... | O'Toole David D | Chief Financial Off ... | Buy | P | 16.95 | 2,000 | 33,900 | 5,000 | 3 K to 5 K (+66.67 %) |
| May 14 2018 | OPNT | OPIANT PHARMACEUTI ... | O'Toole David D | Chief Financial Off ... | Buy | P | 18.85 | 3,000 | 56,550 | 3,000 | 0 to 3 K |
| Jan 08 2018 | OPNT | OPIANT PHARMACEUTI ... | O'Toole David D | Chief Financial Off ... | Option Exercise | A | 24.84 | 13,200 | 327,888 | 13,200 | |
| Sep 14 2017 | OPNT | OPIANT PHARMACEUTI ... | O'Toole David D | Chief Financial Off ... | Option Exercise | A | 36.00 | 150,000 | 5,400,000 | 150,000 | |
| Aug 19 2016 | CAPN | Capnia, Inc. | O'Toole David D | See Remarks | Buy | P | 1.01 | 2,000 | 2,020 | 44,750 | 42.8 K to 44.8 K (+4.68 %) |
| Aug 18 2016 | CAPN | Capnia, Inc. | O'Toole David D | See Remarks | Buy | P | 0.92 | 10,000 | 9,238 | 42,750 | 32.8 K to 42.8 K (+30.53 %) |
| Jun 10 2016 | CAPN | Capnia, Inc. | O'Toole David D | See Remarks | Option Exercise | A | 1.20 | 90,840 | 109,008 | 90,840 | |
| May 16 2016 | CAPN | Capnia, Inc. | O'Toole David D | See Remarks | Buy | P | 1.16 | 5,000 | 5,775 | 32,750 | 27.8 K to 32.8 K (+18.02 %) |
| Jan 11 2016 | CAPN | Capnia, Inc. | O'Toole David D | See Remarks | Option Exercise | A | 1.61 | 60,000 | 96,600 | 60,000 | |
| Nov 17 2015 | CAPN | Capnia, Inc. | O'Toole David D | SVP & Chief Financi ... | Buy | P | 1.79 | 5,000 | 8,950 | 27,750 | 22.8 K to 27.8 K (+21.98 %) |
| Sep 14 2015 | CAPN | Capnia, Inc. | O'Toole David D | SVP & Chief Financi ... | Buy | P | 2.38 | 7,500 | 17,885 | 22,750 | 15.3 K to 22.8 K (+49.18 %) |
| Aug 12 2015 | CAPN | Capnia, Inc. | O'Toole David D | See Remarks | Buy | P | 1.78 | 10,000 | 17,800 | 15,250 | 5.3 K to 15.3 K (+190.48 %) |
| May 19 2015 | CAPN | Capnia, Inc. | O'Toole David D | See Remarks | Option Exercise | A | 4.66 | 30,000 | 139,800 | 30,000 | |
| Mar 16 2015 | CAPN | Capnia, Inc. | O'Toole David D | Chief Financial Off ... | Buy | P | 6.23 | 5,250 | 32,708 | 5,250 | 0 to 5.3 K |
| Dec 16 2011 | RGDX | RESPONSE GENETICS ... | O'Toole David D | Vice President & CF ... | Option Exercise | A | 1.32 | 30,000 | 39,600 | 30,000 | |
| Apr 14 2011 | RGDX | RESPONSE GENETICS ... | O'Toole David D | Vice President & CF ... | Option Exercise | A | 2.25 | 30,000 | 67,500 | 30,000 | |
| May 05 2010 | RGDX | RESPONSE GENETICS ... | O'Toole David D | Chief Financial Off ... | Option Exercise | A | 2.21 | 100,000 | 221,000 | 100,000 |
Page: 1